M. Aihara et al., MOLECULAR ANALYSIS OF SUPPRESSION OF INTERLEUKIN-8 PRODUCTION BY REBAMIPIDE IN HELICOBACTER PYLORI-STIMULATED GASTRIC-CANCER CELL-LINES, Digestive diseases and sciences, 43(9), 1998, pp. 174-180
Interleukin-8 (IL-8) may play an important role in Heloicobacter pylor
i infection-associated chronic active,gastritis and peptic ulcer disea
se in human. We have recently reported that a gastric cancer cell line
, MKN45, produced a massive amount of IL-8 upon coculture with live H.
pylori. Moreover, H. pylori induced the activation of NF-kappa B as w
ell as AP-1, leading to IL-8 gene transcription. In this study, we eva
luated the effect of rebamipide, an antigastritis and antiulcer agent,
on H. pylori-induced IL-8 production. Rebamipide inhibited the produc
tion of IL-8 in several gastric cancer cell lines infected with H. pyl
ori. In addition, rebamipide suppressed H. pylori-induced IL-S gene ex
pression at the transcriptional level as revealed by northern blotting
analysis and luciferase activity in cells that were transfected with
a luciferase expression vector linked with a 5'-flanking region of the
IL-8 gene (bp -133 to +44). Furthermore, rebamipide significantly sup
pressed the NF-kappa B activation by H, pylori infection. These result
s suggest that rebamipide may protect against the mucosal inflammation
associated with H. pylori infection through inhibition of a proinflam
matory cytokine, IL-8.